Pseudomonas aeruginosa is intrinsically resistant to a number of ß-lactams due to the 27 low permeability of its outer-membrane, the constitutive expression of various efflux pumps, 28 and the production of ß-lactamases (5). Acquired resistance to broad-spectrum ß-lactams is 29 increasingly observed in P. aeruginosa. Currently PER-, VEB-, and GES-type enzymes are 30 the most frequently extended-spectrum ß-lactamases (ESBLs) identified in Pseudomonas spp. 31 (5, 7). Therefore, carbapenems are considered crucial for treating many P. aeruginosa-32 associated infections. 33
Pseudomonas aeruginosa is intrinsically resistant to a number of ß-lactams due to the 27 low permeability of its outer-membrane, the constitutive expression of various efflux pumps, 28 and the production of ß-lactamases (5). Acquired resistance to broad-spectrum ß-lactams is 29 increasingly observed in P. aeruginosa. Currently PER-, VEB-, and GES-type enzymes are 30 the most frequently extended-spectrum ß-lactamases (ESBLs) identified in Pseudomonas spp. 31 (5, 7). Therefore, carbapenems are considered crucial for treating many P. aeruginosa-32 associated infections. 33
In Pseudomonas spp., carbapenem resistance may be related either to a decreased 34 bacterial outer-membrane permeability (e.g. loss or modification of the OprD2 porin, or over-35 expression of efflux pumps), often associated with overexpression of ß-lactamases possessing 36 no significant carbapenemase activity (AmpCs) or to expression of true carbapenemases (5, 37 14) . In Pseudomonas spp., those carbapenemases are mostly metallo-ß-lactamases (MBLs) of 38 the VIM-, IMP-, SPM-, GIM-, AIM-, DIM-, and NDM-types and to a lesser extent to Ambler 39 class A carbapenemases of the KPC-and GES-types (GES-2, -4, -5, -6, and -11) (2, 3, 12) . 40
Screening of carbapenemase producers among carbapenem-resistant P. aeruginosa 41 isolates is important since many carbapenemase genes are plasmid-encoded and easily 42 transferable. Phenotypic techniques for in-vitro identification of carbapenemase production, 43 such as the modified Hodge test, are not highly sensitive and specific (10). Detection of 44 MBL-and of KPC producers may be based on the inhibitory properties of several molecules 45 (EDTA and boronic acid, respectively), and requires a significant degree of expertise (9). 46
Indeed, inhibition of carbapenemase activity is more difficult to evidence in P. aeruginosa 47 than in Enterobacteriaceae due to its low outer-membrane permeability (11). Molecular 48 detection of carbapenemase genes is an interesting alternative but remains costly and also 49 requires a high degree of expertise that is not available for non-specialized laboratories (16). 50
Both the phenotypic and molecular techniques are time-consuming and therefore do not 51 on July 5, 2017 by guest http://jcm.asm.org/ Downloaded from correspond to the real clinical need. However, the detection of carbapenemase producers must 52 actually be followed by a rapid adaptation of the antibiotic therapy, and by the isolation of 53 colonized patients in order to prevent the development of nosocomial outbreaks (6). 54
The aim of this study was to determine the value of the newly-developed Carba NP 55 test (8) to discriminate between carbapenemase-and non-carbapenemase-producers among 56
Pseudomonas spp. 57
The Carba NP test is based on biochemical detection of the hydrolysis of the ß-lactam 58 ring of a carbapenem, imipenem, followed by color change of a pH indicator. This test was 59 Scientific, Villebon-sur-Yvette, France), vortexed for 1 min and further incubated at room 64 temperature for 30 min. This bacterial suspension was centrifuged at 10,000 x g at room 65 temperature for 5 min. Thirty microlitres of the supernatant, corresponding to the enzymatic 66 bacterial suspension, was mixed in a well of a 96 well tray with 100 µl of a 1 ml solution 67 made of 3 mg of imipenem monohydrate (Sigma, Saint-Quentin-Fallavier, France) pH 7.8 68 phenol red solution and 0.1 mM ZnSO 4 (Merck Millipore, Guyancourt, France). The phenol 69 red solution used was prepared by taking 2 ml of a phenol red (Merck Millipore) solution 70 0.5% w/v to which 16.6 ml of distilled water was added. The pH value was then adjusted to 71 7.8 by adding drops of 1 N NaOH. Mixture of the phenol red solution and the enzymatic 72 suspension being tested was incubated at 37°C for a maximum of 2 h. Test results were 73 interpreted by technicians who were blinded to the identity of the samples. 74
Thirty-six carbapenemase-producing isolates belonging to several Pseudomonas 75 species, isolated from various clinical samples and being of global origin have been included 76 content at the molecular level. This collection also contained 72 strains being representative 78 of the main ß-lactam resistance phenotypes and ß-lactamase diversity identified in 79
Pseudomonas spp. (including ESBLs of PER-, VEB-, BEL-, SHV-, TEM-, and OXA-types) 80 (Table 2 ). In addition, most of those strains were resistant to carbapenems. 81
The Carba NP test differentiated the carbapenemase producers, with the exception of 82 several GES-type producers (Table 1) , from those isolates being carbapenem-resistant due to 83 non-carbapenemase-mediated mechanisms (the most frequent ones) such as combined 84 mechanisms of resistance (outer-membrane permeability defect +/-associated with 85 overproduction of cephalosporinase and/or ESBLs) ( Table 2 ). The specificity and sensitivity 86 of the test were found to be 100% and 94.4%, respectively. Interestingly, a carbapenemase 87 activity was detected in the two carbapenemase producers (IMP-1-producing P. stutzeri 88 PB207 and P. putida NTU 92/99) that were basically susceptible to carbapenems (MIC ≤ 2 89 µg/ml) according to the CLSI guidelines (1) ( Table 1) . 90
The Carba NP test has multiple benefits for detecting carbapenemase activity in non 91 fermenters such as in Pseudomonas spp.. It eliminates the need of in-vitro detection of 92 carbapenemase activity (Hodge test) and of ß-lactamase inhibitor-based phenotypic 93 techniques (boronic acid for KPC, EDTA for MBLs) that both require at least 24 to 72 h to be 94 performed. The Carba NP test is the first technique available to identify carbapenemase 95 producers with such high specificity, sensitivity, and rapidity (less than 2 h). However, the 96 absence of detection of GES-type carbapenemases has to be considered, especially in 97 geographical regions with high prevalence (i.e. Brazil, South Africa). The GES-type 98 carbapenemases are point mutant analogues of the ESBL GES-1 that possess an additional overexpressing MexX/Y-OprM efflux pump (n°9), P. aeruginosa 3-12 overexpressing the 182 chromosomal AmpC (n°10), P. aeruginosa GES-1 (n°11), P. aeruginosa GES-9 (n°12), P. 183 aeruginosa ED OXA-28 (n°13), P. aeruginosa OXA-32 (n°14), P. aeruginosa SHV-2a 184 (n°15), P. aeruginosa SHV-5 (n°16), P. aeruginosa PER-1 (n°17), P. aeruginosa VEB-1 185 (n°18), P. aeruginosa BEL-1 (n°19). 186
Carbapenemase producers are as follows; P. aeruginosa 16 SPM-1 (n°20), P. stutzeri DIM-1 187 (n°21), P. aeruginosa P13 KPC-2 (n°22), P. aeruginosa PA-2 KPC-2 (n°23), P. aeruginosa 188 VIM-1 (n°24), P. fluorescens COU VIM-2 (n°25), P. aeruginosa REZ VIM-2 (n°26), P. 189 putida VIM-2 (n°27), P. stutzeri VIM-2 (n°28), P. aeruginosa CAS VIM-4 (n°29), P. 190 aeruginosa JAC VIM-4 (n°30), P. aeruginosa 1287 IMP-1 (n°31), P. stutzeri PB207 IMP-1 191 (n°32), P. putida NTU 92/99 IMP-1 (n°33), P. aeruginosa 0607097 IMP-2 (n°34), P. 192 aeruginosa IMP-13 (n°35), P. aeruginosa 453 NDM-1 (n°36), P. aeruginosa 353 NDM-1 193 (n°37), P. aeruginosa 73-56 GIM-1 (n°38), P. aeruginosa WCH2677 AIM-1 (n°39), P. 194 fluorescens BIC-1 (n°40), P. aeruginosa GW-1 GES-2 (n°41), P. aeruginosa Note that strains 41 and 42 gave false-negative results. 196 
